Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
Citation
Hager , K J , Pérez Marc , G , Gobeil , P , Diaz , R S , Heizer , G , Llapur , C , Makarkov , A I , Vasconcellos , E , Pillet , S , Riera , F , Saxena , P , Geller Wolff , P , Bhutada , K , Wallace , G , Aazami , H , Jones , C E , Polack , F P , Ferrara , L , Atkins , J , Boulay , I , Dhaliwall , J , Charland , N , Couture , M M J , Jiang-Wright , J , Landry , N , Lapointe , S , Lorin , A , Mahmood , A , Moulton , L H , Pahmer , E , Parent , J , Séguin , A , Tran , L , Breuer , T , Ceregido , M-A , Koutsoukos , M , Roman , F , Namba , J , D'Aoust , M-A , Trepanier , S , Kimura , Y , Ward , B J & CoVLP Study Team 2022 , ' Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine ' , The New England Journal of Medicine , vol. 386 , 2201300 , pp. 2084-2096 . https://doi.org/10.1056/NEJMoa2201300